Jie LIU, Yi XIAO. Wegener's Granulomatosis Combined with Pulmonary Tuberculosis: Report of 8 Cases and Literature Review[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(2): 167-170.
Citation: Jie LIU, Yi XIAO. Wegener's Granulomatosis Combined with Pulmonary Tuberculosis: Report of 8 Cases and Literature Review[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(2): 167-170.

Wegener's Granulomatosis Combined with Pulmonary Tuberculosis: Report of 8 Cases and Literature Review

More Information
  • Corresponding author:

    XIAO Yi Tel:010-65295037, E-mail:xiaoyipumch@yahoo.com.cn

  • Received Date: July 31, 2010
  • Issue Publish Date: October 29, 2010
  •   Objective  To analyze the clinical manifestations of patients with Wegener's granulomatosis (WG) and pulmonary tuberculosis (TB).
      Methods  We retrospectively analyzed the clinical data of 8 patients with Wegener's granulomatosis combined with pulmonary tuberculosis in Peking Union Medical College Hospital from May 1990 to May 2010.
      Results  There were 5 men and 3 women aged 19-70 years. Five patients were initially diagnosed as Wegener's granulomatosis but were confirmed to be with pulmonary tuberculosis during corticosteroid therapy. All these five patients had positive acid-fast bacilli smear test results, and four of them denied past a history of tuberculosis or tuberculosis exposure. Two were diagnosed as Wegener's granulomatosis and pulmonary tuberculosis almost the same time. In the remaining one case, tuberculosis was diagnosed firstly, and then Wegener's granulomatosis was also identified. The most common clinical manifestation in lung was hemoptysis, followed by cough and expectoration. Other involved organs included kidney (abnormal red blood cells in urine) and ear/nose/throat (suppuration and hearing impairment). Management was mainly based on anti-TB therapy and enhanced corticosteroid therapy.
      Conclusions  Patients with Wegener's granulomatosis combined with pulmonary tuberculosis are not uncommon. Early diagnosis and treatment can improve the prognosis.
  • [1]
    Cordier JF, Valeyre D, Guillevin L.Pulmonary Wegener's granulomatosis:a clinical and imaging study of 77 cases[J]. Chest, 1990, 97:906-912. DOI: 10.1378/chest.97.4.906
    [2]
    Duna GF, Galperin C, Hoffman GS.Wegener's granulomatosis[J]. Rheum Dis Clin North Am, 1995, 21:949-986. https://pubmed.ncbi.nlm.nih.gov/14968341/
    [3]
    Hagen EC, Daha MR, Hermans J, et al.Diagnostic value of standandized assays for anti-neutrophil cytoplasmic antibodies in idiopathicsy stemic vasculitis.EC/BCR Project for ANCA Assay Standardization[J]. Kidney Int, 1998, 53:743-753. DOI: 10.1046/j.1523-1755.1998.00807.x
    [4]
    Pradhan VD, Badakere SS, Ghosh K, et al.Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener's granulomatosis [J]. Indian J MedSci, 2004, 58:283-288. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=81391c72a549c8b1d5961370edf4b209
    [5]
    Flores-Suárez LF, Cabiedes J, Villa AR, et al.Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis[J]. Rheumatology, 2003, 42:223-229. DOI: 10.1093/rheumatology/keg066
    [6]
    Esquivel-Valerio JA, Flores-Suárez LF, Rodríguez-Amado J, et al, Antineutrophil cytoplasm autoantibodies inpatients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation [J]. Clin Exp Rheumatol, 2010, 28(1 Suppl57):35-39. http://www.ncbi.nlm.nih.gov/pubmed/20412700/
    [7]
    Stone JH, Merkel PA, Spiera R, et al.Rituximab versus cyclophosphamide for ANCA-associated vasculitis[J]. N Engl J Med, 2010, 363:221-232. DOI: 10.1056/NEJMoa0909905
    [8]
    Toyoshima M, Chida K, Suda T, et al.Wegener's granulomatosis responding to antituberculous drugs[J]. Chest, 2001, 119:643-645. DOI: 10.1378/chest.119.2.643
  • Related Articles

    [1]WANG Shuo, DENG Yuntian, PENG Huan, ZHANG Xiangfeng. Progress in the Treatment of Non-small Cell Lung Cancer with Immune Checkpoint Inhibitors[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 409-415. DOI: 10.12290/xhyxzz.2022-0151
    [2]DAI Liyuan, SHI Yuankai, HAN Xiaohong. Advances in Dynamic Monitoring of Immune Checkpoint Inhibitors as the Prognostic Markers for Advanced Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 287-295. DOI: 10.12290/xhyxzz.2021-0608
    [3]WU Li'na, GAO Yi, LI Wosong, LIU Yong, QIN Xiaosong. Application Value of Serum Kreb Von Den Lungen-6 in the Adjuvant Treatment of Lung Injury after Non-small Cell Lung Cancer Surgery[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 496-502. DOI: 10.12290/xhyxzz.2021-0308
    [4]LI Guo-yu, HE Ming. Research Progress of Targeted Therapy at Rare Targets for Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(2): 268-274. DOI: 10.3969/j.issn.1674-9081.2020.00.019
    [5]Lei LIU, Jia-qi ZHANG, Gui-ge WANG, Cheng HUANG, Li LI, Nai-xin LIANG, Shan-qing LI. Fibroblast Growth Factor Receptor 1 in Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 666-672. DOI: 10.3969/j.issn.1674-9081.2019.06.020
    [6]Jia-qi ZHANG, Lei LIU, Gui-ge WANG, Wen-liang BAI, Shan-qing LI. Clinical Pathological Features and Prognosis of Non-small Cell Lung Cancer with Skip N2 Lymph Node Metastasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015
    [7]Xiao-na JIN, Nai-xin LIANG, Meng-zhao WANG, Bing JIA, Xi-min SHI, Shan-qing LI, Fang LI, Fan WANG, Zhao-hui ZHU. Integrin Receptor Imaging 99mTc-3PRGD2 SPECT/CT in Diagnosis and Lymph Node Staging of Non-Small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(5): 327-333. DOI: 10.3969/j.issn.1674-9081.2016.05.002
    [8]Xiao-hua SHI, Sha-fei WU, Qing LING, Zhen HUO, Zhi-yong LIANG. Clinicopathological Features and Immunohistochemical Phenotypes of Adenoid Cystic Carcinoma of the Uterine Cervix[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(3): 197-201. DOI: 10.3969/j.issn.1674-9081.2015.03.007
    [9]Nai-xin LIANG, Ya-xin LIU, Lei LIU, Shan-qing LI. Co-mutation of PIK3CA and Other Oncogenes in Patients with Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(3): 186-190. DOI: 10.3969/j.issn.1674-9081.2015.03.005
    [10]Xiao-hua SHI, Zhi-yong LIANG, Huan-wen WU, Xin-yu REN, Tong-hua LIU. Effect of RNA Interference Plasmid on the Expression of Oncogene AKT2 in Pancreatic Cancer Cell Line Panc-1[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 102-108. DOI: 10.3969/j.issn.1674-9081.2012.01.021

Catalog

    Article Metrics

    Article views PDF downloads Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close